# ACUTAAS share price, delivery % and history — Acutaas Chemicals Limited

> Delivery percentage for Acutaas Chemicals Limited (ACUTAAS) against its own history, with 1,252 sessions of split-adjusted NSE data from 2021 — plus moving averages, RSI and the 52-week range.

Canonical: https://patternsradar.com/s/ACUTAAS

NSE · equity · [Healthcare](https://patternsradar.com/stocks/sector/healthcare.md) · [Pharmaceuticals & Biotechnology](https://patternsradar.com/stocks/industry/pharmaceuticals-biotechnology.md)

## Latest session

- Close: 3,279.4 INR (-0.75% on the day), 2026-09-30
- Delivery: 53.25% of volume taken to demat (20-day average 49.06%)
- Volume: 3.49L shares, turnover ₹114.6Cr
- Relative volume: 1× of its own 20-day average

## Technicals

- RSI(14): 49.93
- ATR(14): 126.44
- SMA 50: 3,267.12, SMA 200: 2,656.28
- 52-week range: 1,302 – 3,740 (-12.32% from the high)

## Performance

- 1 week 0.43%, 1 month 3.76%, 3 months -11.17%
- 6 months 28.86%, 1 year 126.15%

## Delivery percentage

- Latest: 53.25% (2026-09-30)
- 20-day average: 49.06%
- 1-year average: 48.97%
- Percentile against its own history: 74th
- Range: 15.47% – 91.66% across 1,248 sessions with a reading

Over the last 20 sessions ACUTAAS settled 49.1% of its traded quantity, which is above average for an NSE equity. That is in line with its own one-year average of 49.0%. The latest session ranks higher than 74% of the 1,248 sessions on record for it.

[What delivery percentage measures](https://patternsradar.com/learn/delivery-percentage.md). [Scan the whole market on delivery](https://patternsradar.com/scans/delivery.md).

## Fundamentals

- Market cap: 26,848.8 crore
- P/E (TTM): 69.31 — NULL when trailing earnings are negative or unfiled, never a misleading number
- EPS (TTM): 47.31 INR, split-adjusted to match the price series
- Revenue growth: 59.08% YoY, -23.82% QoQ
- Profit growth: 70.4% YoY, -44.15% QoQ

Compound annual growth, trailing-twelve-month against the same measure N years earlier:

| Window | Revenue | Profit |
| --- | --- | --- |
| 2y | 40.51% | 206.77% |
| 3y | 32.52% | 65.68% |
| 4y | 28.39% | 51.73% |

## Quarterly results

Last 8 filed quarters, consolidated basis, in rupees crore as filed.

| Quarter | Revenue | Total expenses | Profit before tax | Net profit | EPS | Net margin |
| --- | --- | --- | --- | --- | --- | --- |
| 2024-09-30 | 246.7 | 205.1 | 50 | 37.6 | 4.69 | 15.23% |
| 2024-12-31 | 275 | 213.3 | 63.3 | 45.4 | 5.68 | 16.53% |
| 2025-03-31 | 308.5 | 231.4 | 82.8 | 62.7 | 3.9 | 20.33% |
| 2025-06-30 | 207.2 | 165.1 | 58.1 | 44 | 5.41 | 21.24% |
| 2025-09-30 | 306.2 | 219.9 | 96.2 | 71.9 | 8.82 | 23.47% |
| 2025-12-31 | 393.2 | 253.2 | 144.7 | 106.2 | 13.19 | 27.02% |
| 2026-03-31 | 432.8 | 260.1 | 183.8 | 134.3 | 16.09 | 31.03% |
| 2026-06-30 | 329.7 | 227.6 | 103.9 | 75 | 9.07 | 22.75% |

A quarterly filing with NSE carries a profit and loss only. There is no balance sheet behind it, and so no debt, cash flow or return-on-capital figure in this dataset. EPS is restated onto the split-adjusted basis the price series uses; every rupee figure is exactly as filed.

## Recent filings

- 2026-09-17: dividend
- 2026-07-24: results for 2026-06-30 both — https://nsearchives.nseindia.com/corporate/ixbrl/INTEGRATED_FILING_INDAS_177818_24072026162914_iXBRL_WEB.html
- 2026-04-30: results for 2026-03-31 both — https://nsearchives.nseindia.com/corporate/ixbrl/INTEGRATED_FILING_INDAS_154985_30042026190510_iXBRL_WEB.html
- 2026-01-28: results for 2025-12-31 both — https://nsearchives.nseindia.com/corporate/ixbrl/INTEGRATED_FILING_INDAS_138043_28012026180912_iXBRL_WEB.html
- 2025-10-17: results for 2025-09-30 both — https://nsearchives.nseindia.com/corporate/ixbrl/INTEGRATED_FILING_INDAS_120701_17102025190400_iXBRL_WEB.html
- 2025-09-18: dividend
- 2025-07-30: results for 2025-06-30 both — https://nsearchives.nseindia.com/corporate/ixbrl/INTEGRATED_FILING_INDAS_107283_30072025165745_iXBRL_WEB.html
- 2025-05-02: results for 2025-03-31 both — https://nsearchives.nseindia.com/corporate/ixbrl/INTEGRATED_FILING_INDAS_89130_02052025180128_iXBRL_WEB.html

Dated by the day the company broadcast the filing. 28 events are indexed for this instrument.

## About the instrument

- Listed: 2021-09-14 — latest session 2026-09-30 (1,252 sessions)
- ISIN: INE00FF01025
- Series: EQ
- Liquidity rank: #265 by 20-day average turnover — not index membership

Delivery figures come from NSE's daily reports and are unavailable for older sessions. Prices are end-of-day, split- and bonus-adjusted, from the eod2 dataset.

## More in Pharmaceuticals & Biotechnology

- [DIVISLAB](https://patternsradar.com/s/DIVISLAB.md) — Divi's Laboratories Limited (Pharmaceuticals & Biotechnology)
- [LAURUSLABS](https://patternsradar.com/s/LAURUSLABS.md) — Laurus Labs Limited (Pharmaceuticals & Biotechnology)
- [WOCKPHARMA](https://patternsradar.com/s/WOCKPHARMA.md) — Wockhardt Limited (Pharmaceuticals & Biotechnology)
- [SUNPHARMA](https://patternsradar.com/s/SUNPHARMA.md) — Sun Pharmaceutical Industries Limited (Pharmaceuticals & Biotechnology)
- [MOREPENLAB](https://patternsradar.com/s/MOREPENLAB.md) — Morepen Laboratories Limited (Pharmaceuticals & Biotechnology)
- [DRREDDY](https://patternsradar.com/s/DRREDDY.md) — Dr. Reddy's Laboratories Limited (Pharmaceuticals & Biotechnology)
- [SYMBIOTEC](https://patternsradar.com/s/SYMBIOTEC.md) — SYMBIOTEC (Pharmaceuticals & Biotechnology)
- [GLAND](https://patternsradar.com/s/GLAND.md) — Gland Pharma Limited (Pharmaceuticals & Biotechnology)
- [ZYDUSLIFE](https://patternsradar.com/s/ZYDUSLIFE.md) — Zydus Lifesciences Limited (Pharmaceuticals & Biotechnology)
- [TORNTPHARM](https://patternsradar.com/s/TORNTPHARM.md) — Torrent Pharmaceuticals Limited (Pharmaceuticals & Biotechnology)
- [LUPIN](https://patternsradar.com/s/LUPIN.md) — Lupin Limited (Pharmaceuticals & Biotechnology)
- [AHCL](https://patternsradar.com/s/AHCL.md) — Anlon Healthcare Limited (Pharmaceuticals & Biotechnology)

[All Pharmaceuticals & Biotechnology stocks on the NSE](https://patternsradar.com/stocks/industry/pharmaceuticals-biotechnology.md) · [All Healthcare stocks on the NSE](https://patternsradar.com/stocks/sector/healthcare.md)

Charts and the full bar history are on the rendered page: https://patternsradar.com/s/ACUTAAS.

---

Price and delivery data from the [eod2](https://github.com/BennyThadikaran/eod2) dataset: National Stock Exchange of India end-of-day files, split- and bonus-adjusted, updated after each close. Not affiliated with or endorsed by NSE. PatternsRadar is a research tool. Nothing here is investment advice or a recommendation to buy or sell anything.